供应商 · 生产商
KitOzyme
KitoZyme基于其专利配料,为健康、食品、葡萄酒、个人护理和农业设计制造创新、绿色且安全的解决方案。 真菌源生物聚合物领域的全球领导者。
简介
- 行业
- 化妆品, 植物保护, 包装与塑料
- 主题
- 甲壳素与壳聚糖
- 角色
- 生产商 — “…2000 as a spin-off from the University of Liège, the company is led by CEO François Blondel. It operates as a…”
- 为何属于生物经济
- KitoZyme是一家生物技术公司,以真菌为原料生产功能性生物聚合物(壳聚糖和几丁质-葡聚糖),应用于农业、食品、葡萄酒和个人护理领域。
- 发现途径
- [Rubric] Belgium · chitosan; [Rubric] Belgium · enzymes; [Rubric] Ireland · chitosan; [Rubric] United Kingdom · chitosan
供应的生物解决方案 0
尚未被列为已评级方案的供应商。
产品与服务
子公司: KiOmed Pharma · BiOkuris
状态
近期新闻 5
精选自公开商业披露与权威行业资讯。引用或用于商业决策前,请以官方原文公告为准。
- 2026-08-30 Wat doet een molecule uit zwammen in onze knieën, tandpasta en wijn? Kitozyme uit Herstal scoort er wereldwijd mee | Collector: Breaking News, World News, … collector.com.trSummary: The article explains that in Wallonia, large-scale production of chitosan—a molecule with notable properties—occurs from plants rather than animals. It notes that Chinese fraudsters covet this know-how and mentions Kitozyme, a company from Herstal, benefiting globally …
- 2026-08-03 François Blondel (CEO de Kitozyme) : "Je rêve d'un ministère de l'Audace" - Trends-Tendances trends.levif.beKitozyme is a profitable, cash-flow positive company that serves as the core producer of the foundational biopolymer chitosan derived from mushrooms, which underpins its sister ventures Kiomed and Biokuris and supports a broader, regionally centered, globally leading platform in …
- 2026-05-08 Ce jeudi, nous avons eu l’opportunité de visiter les installations de KitOzyme ainsi que de sa filiale KiOmed Pharma, deux entreprises liégeoises issues de … linkedin.comKitOzyme is a Liège-based company, developed from the University of Liège ecosystem, producing innovative biomaterials from fungal chitosan and chitin-glucan for medical devices, dietary supplements, and life sciences applications. It is part of a spin-off with KiOmed Pharma, …
- 2026-05-06 Kitozyme, Kiomed et Biokuris : le trio gagnant de François Blondel - La Libre lalibre.beKitozyme, plus Kiomed et Biokuris, forme un groupe wallon de biopharmacie dirigé par François Blondel. En 2025, le groupe affiche une croissance solide (Kitozyme +20%, Kiomed +31%, Biokuris +39%), un chiffre d’affaires de 23 M€ et un EBITDA de 7 M€, avec Kitozyme et Kiomed déjà …
- 2026-03-12 When green chemistry meets beauty vision: KitoZyme x L’Oréal 🌿✨ linkedin.comKitoZyme collaborated with L’Oréal for over a decade to fuse performance, sustainability, and transparency in beauty, culminating in the first cleansing products featuring their patented vegetal chitosan, KiOSmetine (KiOsmetine).
关系网络:股东、合作伙伴、同类
股权与投资方 3
| 母公司 | KiOmed Pharma |
| 子公司 | KiOmed Pharma |
| 子公司 | BiOkuris |
合作与交易 2
| 交易对手 | KiOmed Pharma and Biokuris (subsidiaries) …The company celebrated its 25th anniversary in 2026 and unveiled a new logo.… |
| 合作 | KitoZyme positions itself as a leader …development and partnerships for sustainable biocontrol and green solutions (evidenced by strategic partnerships and microcapsule innovations).
Overall: KitoZyme positions itself as a leader in …… |
同类企业
EUROLYSINE · GENIBIO · Meurens Natural · Ennolys by Lesaffre · Alderys · Golgemma · BIOSSENT · JRS J. Rettenmaier & Söhne
公司信息
注册编号
- VAT Number: BE 0473.676.932
- PEPPOL ID: 0208:0473676932
融资
- 最近一轮: Venture · 2013-01-24
核心运营指标与商业动态汇编自企业年报、行业披露及公开工商信息,法定登记编码以主管部门官方登记为准。
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录